Positive CT scan for lung cancer may resolve

Key points
- Many positive CT scans for lung cancer screening resolve after short-term follow-up, doctors have observed.
- The value of CT screening for lung cancer is unclear.
- Positive CT screening for lung cancer usually results in the diagnosis of early stage I lung cancer, the authors explain, but benign lesions are also found.
- Libby from the Weill Cornell Medical Center in New York and colleagues reviewed their experience with first-time and repeat CT screenings to determine if short-term CT follow-up might shorten the workup of lesions.
Many positive CT scans for lung cancer screening resolve after short-term follow-up, doctors have observed.
The value of CT screening for lung cancer is unclear. In people at high risk for the disease, CT scanning may detect early lung cancer, but it's usefulness as a screening tool is limited because it misses tumors in certain areas of the lung and often falsely identifies harmless spots as being cancerous.
Positive CT screening for lung cancer usually results in the diagnosis of early stage I lung cancer, the authors explain, but benign lesions are also found.
Dr. Daniel M. Libby from the Weill Cornell Medical Center in New York and colleagues reviewed their experience with first-time and repeat CT screenings to determine if short-term CT follow-up might shorten the workup of lesions.
Among the 41 individuals who had follow-up CT scans within 2 months of the initial scan, five patients had complete resolution and seven patients had partial resolution of the original findings, the authors report.
Eight of 10 patients with patchy consolidated spots showed complete or partial resolution after antibiotic therapy, the results indicate, compared with 4 of 31 patients with lesions.
Based on these findings, 12 patients would not require further tests and would simply be asked to return for a repeat screening in 1 year, the researchers note.
The results were similar among 39 patients who returned for follow-up CT scan within 2 months of their annual repeat screening, the report indicates. Sixteen of these patients had complete resolution, and 13 patients had partial resolution of their abnormal findings.
In both groups of patients, none of those who showed partial resolution had subsequent lesion growth or cancer, the investigators report. However, for 37 patients whose nodules remained unchanged or grew, 17 cancers were subsequently identified.
"On the basis of this study," the authors conclude, "we recommend a course of antibiotics followed by another CT within 2 months to people with patchy consolidation or nonsolid opacities detected on the baseline screening and all those with new nodules on repeat screening."
"It must be emphasized that the use of antibiotics and short-term CT follow-up is only one of the options in the regimen of CT screening for lung cancer," the researchers add, "and further research in this area promises to continue to improve the efficiency of CT screening for lung cancer."
SOURCE: Chest April 2006.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsResearchers find new approach to treat drug-resistant HER2-positive breast cancer
Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy. Using human cell lines of the HER2-positive breast cancer subtype,…
10 April 2015
NewsNo association between lung cancer risk in women and reproductive history or hormone use
The Women's Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support…
9 April 2015
NewsMoffitt researchers discover novel mechanism controlling lung cancer stem cell growth
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many…




